Publication not explained

This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.

If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.

Featured Image

Read the Original

This page is a summary of: Societal savings in patients with advanced non-squamous non-small-cell lung cancer receiving bevacizumab-based versus non-bevacizumab-based treatments in France, Germany, Italy, and Spain, ClinicoEconomics and Outcomes Research, October 2012, Taylor & Francis,
DOI: 10.2147/ceor.s34188.
You can read the full text:

Read

Contributors

The following have contributed to this page